EyePoint reports DURAVYU/LUGANO topline wet AMD data and sets DME
EyePoint reported August 2026 topline DURAVYU/LUGANO wet AMD data and set LUCIA and DME toplines for Q4 2026 and Q4 2027. The company granted a non-statutory option for up to 3,000 shares at $3.66 with a ten-year term and four-year vesting tied to continued employment.